Roux-en-Y胃旁路术前后Barrett食管的转归
该研究回顾性分析了19例活检证实的Barrett食管(BE)并接受腹腔镜Roux-en-Y胃旁路术(LRYGB)的重度肥胖患者,其中14例有至少1年随访数据。术后6/14(42.9%)患者BE组织学逆转为正常食管黏膜,BMI由46.6降至30.3 kg/m2。作者推荐LRYGB作为重度肥胖合并BE患者的减重与抗反流联合术式,但仍建议按标准监测方案长期随访。
要点
- LRYGB术后42.9%(6/14)患者BE组织学逆转为正常黏膜
- 14例中13例(92.8%)术后第一年坚持PPI治疗
- BMI由46.6降至30.3 kg/m2,但BE患者仍需长期内镜监测
核心结论
- LRYGB可作为重度肥胖合并BE患者兼顾减重与抗反流的有效术式,短期随访中相当部分患者BE获得内镜与组织学逆转。
- 作者仍建议BE患者按标准监测方案进行长期随访。
研究设计与样本
- 单中心回顾性综述,纳入活检证实的BE并接受LRYGB的患者共19例。
- 其中14例具备至少1年临床、内镜或组织学数据,7例有胃食管反流症状。
主要发现
- 14例中6例(42.9%)术后BE组织学逆转为正常食管黏膜,无持续BE证据。
- 14例中13例(92.8%)报告术后第一年坚持PPI治疗。
- 14例患者BMI由46.6改善至30.3 kg/m2。
- 全部19例均为短段BE,其中1例伴低级别异型增生。
关键数值与推荐
- BE逆转:6/14(42.9%)。
- PPI依从:13/14(92.8%)。
- BMI:46.6→30.3 kg/m2。
临床怎么用
- 对重度肥胖合并BE患者,可考虑LRYGB作为同时处理肥胖与反流的术式选择。
- 术后应强调PPI依从性,并按标准监测方案长期随访BE。
局限性
- 回顾性单中心设计,样本量小(19例,随访分析14例)。
- 随访时间短,缺乏长期BE逆转与复发数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Barrett's esophagus (BE) has been associated with obesity and metabolic syndrome. Laparoscopic Roux-en-Y gastric bypass (LRYGB) may represent a surgical approach which addresses both severe obesity and BE. LRYGB diverts bile away from the gastric pouch and esophagus due to the long Roux limb, and very little acid is produced in the cardia-based gastric pouch. Furthermore, surgically induced weight loss may diminish systemic inflammation, which may contribute to metaplastic changes in the esophagus. Moreover, improved compliance with proton-pump inhibitor therapy, as a consequence of enrolling in a bariatric program, will decrease acid production further. Decreased duodeno-gastro-esophageal reflux should lead to decreased BE. In this study we examine the effect of LRYGB on regression of BE. METHODS AND PROCEDURES: We performed a review of all patients with biopsy proven BE, who underwent LRYGB at our institution. A total of 19 patients were identified. A subset of those patients was identified who had at least 1 year of clinical, endoscopic, or histological data, comprising a total of 14 patients. Seven of these patients had symptoms of gastroesophageal reflux. All 19 patients had short-segment BE. One patient had low-grade dysplasia. RESULTS: Post-LRYGB, 6 of 14 (42.9%) patients had histologic regression of BE to normal esophageal mucosa, with no evidence of ongoing BE. 13 of 14 patients (92.8%) reported compliance with continuing PPI therapy for at least the first year after surgery. Body mass index for the group of 14 patients improved from 46.6 to 30.3 kg/m2. CONCLUSIONS: We recommend LRYGB as an effective combined bariatric and anti-reflux surgical procedure for patients with severe obesity and BE. In short-term follow-up, LRYGB achieved endoscopic and histologic regression to normal mucosa in a substantial number of the patients in our series. Long-term follow-up for patients with BE according to standard surveillance protocols is still recommended.
引用
- Andrew B, Alley JB, Aguilar CE, et al. Barrett's esophagus before and after Roux-en-Y gastric bypass for severe obesity. Surg Endosc. 2017. PMID: 28779257. doi:10.1007/s00464-017-5768-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。